Nexavar Shown To Significantly Extend Survival For Patients With Advanced Liver Cancer

Tue, 13 Feb 2007 02:00 PM EST

... Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer. [click link for full article] ...